We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

2cureX AB (2CUREX) NPV

Sell:13.72 SEK Buy:13.96 SEK Change: 0.16 SEK (1.13%)
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
Sell:13.72 SEK
Buy:13.96 SEK
Change: 0.16 SEK (1.13%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
Sell:13.72 SEK
Buy:13.96 SEK
Change: 0.16 SEK (1.13%)
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.

Contact details

Address:
c/o Mazars SET Revisionsbyra AB, Box 159
LANDSKRONA
261 22
Sweden
Telephone:
+ ()
Website:
https://www.2curex.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
2CUREX
ISIN:
SE0010468124
Market cap:
248.22 million SEK
Shares in issue:
17.29 million
Sector:
Health Care Equipment
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Povl-Andre Bendz
    Independent Chairman of the Board
  • Fernando Andreu
    Chief Executive Officer
  • Ole Thastrup
    Deputy Chief Executive Officer, CSO, Executive Director
  • Kenneth Johansen
    Chief Financial Officer
  • Juergen Kupper
    Managing Director of 2cureX GmbH
  • Grith Hagel
    Head of Project Management
  • Henrik Harling
    Chief Medical Officer
  • Maarten van der Linden
    Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.